CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells

by Xiaoting Huang, Leyang Xiang, Baiyao Wang, Jijie Hu, Chunshan Liu, Anbang Ren, Kunpeng Du, Gengtai Ye, Yingying Liang, Yunqiang Tang, Dinghua Yang, Yawei Yuan
Published 2021-03-01

Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer

by Chao Zhang, Shutao Zhao, Xudong Wang
Published 2021-01-01

CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients

by Xin Li, Ling Chen, Chuan Gu, Qiaoli Sun, Jia Li
Published 2020-08-01

Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment

by Yanbin Zhao, Minghui Zhang, Haihong Pu, Shengyue Guo, Shuai Zhang, Yan Wang
Published 2021-01-01

Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy

by Sandra Martinez-Morilla, Jon Zugazagoitia, Pok Fai Wong, Harriet M. Kluger, David L. Rimm
Published 2021-01-01

Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients

by Young Wha Koh, Jae-Ho Han, Seokjin Haam, Joonho Jung, Hyun Woo Lee
Published 2019-10-01

Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers

by Hiroto Takeuchi, Satoru Konnai, Satoru Konnai, Naoya Maekawa, Erina Minato, Yoshiki Ichikawa, Atsushi Kobayashi, Tomohiro Okagawa, Shiro Murata, Shiro Murata, Kazuhiko Ohashi, Kazuhiko Ohashi
Published 2020-06-01